| Cisplatin-based adjuvant chemotherapy in patients with completely resected non–small-cell lung cancer International Adjuvant Lung Cancer Trial Collaborative Group New England Journal of Medicine 350 (4), 351-360, 2004 | 2560 | 2004 |
| CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by … M Pfreundschuh, L Trümper, A Österborg, R Pettengell, M Trneny, K Imrie, ... The lancet oncology 7 (5), 379-391, 2006 | 2150 | 2006 |
| DNA repair by ERCC1 in non–small-cell lung cancer and cisplatin-based adjuvant chemotherapy KA Olaussen, A Dunant, P Fouret, E Brambilla, F André, V Haddad, ... New England Journal of Medicine 355 (10), 983-991, 2006 | 2133 | 2006 |
| A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy RA Olie, AP Simões-Wüst, B Baumann, SH Leech, D Fabbro, RA Stahel, ... Cancer research 60 (11), 2805-2809, 2000 | 894 | 2000 |
| Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma A Scherpereel, P Astoul, P Baas, T Berghmans, H Clayson, P De Vuyst, ... European Respiratory Journal 35 (3), 479-495, 2010 | 618 | 2010 |
| CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the … M Pfreundschuh, E Kuhnt, L Trümper, A Österborg, M Trneny, L Shepherd, ... The lancet oncology 12 (11), 1013-1022, 2011 | 595 | 2011 |
| Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non–small-cell lung cancer: a … DC Betticher, SF Hsu Schmitz, M Totsch, E Hansen, C Joss, C Von Briel, ... Journal of clinical oncology 21 (9), 1752-1759, 2003 | 442 | 2003 |
| CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells S Aigner, ZM Sthoeger, M Fogel, E Weber, J Zarn, M Ruppert, Y Zeller, ... Blood, The Journal of the American Society of Hematology 89 (9), 3385-3395, 1997 | 389 | 1997 |
| Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes T Le Chevalier, G Scagliotti, R Natale, S Danson, R Rosell, R Stahel, ... Lung cancer 47 (1), 69-80, 2005 | 382 | 2005 |
| Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma W Weder, RA Stahel, J Bernhard, S Bodis, P Vogt, P Ballabeni, ... Annals of oncology 18 (7), 1196-1202, 2007 | 355 | 2007 |
| 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up J Vansteenkiste, L Crinò, C Dooms, JY Douillard, C Faivre-Finn, E Lim, ... Annals of Oncology 25 (8), 1462-1474, 2014 | 345 | 2014 |
| Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop R Pirker, FJF Herth, KM Kerr, M Filipits, M Taron, D Gandara, FR Hirsch, ... Journal of Thoracic Oncology 5 (10), 1706-1713, 2010 | 321 | 2010 |
| Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation S Hopkins-Donaldson, A Ziegler, S Kurtz, C Bigosch, D Kandioler, ... Cell Death & Differentiation 10 (3), 356-364, 2003 | 312 | 2003 |
| CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment … J Lundin, A Osterborg, G Brittinger, D Crowther, H Dombret, A Engert, ... Journal of Clinical Oncology 16 (10), 3257-3263, 1998 | 294 | 1998 |
| 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer WEE Eberhardt, D De Ruysscher, W Weder, C Le Péchoux, P De Leyn, ... Annals of Oncology 26 (8), 1573-1588, 2015 | 292 | 2015 |
| Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma W Weder, P Kestenholz, C Taverna, S Bodis, D Lardinois, M Jerman, ... Journal of clinical oncology 22 (17), 3451-3457, 2004 | 292 | 2004 |
| Circulating DNA: a new diagnostic gold mine? A Ziegler, U Zangemeister-Wittke, RA Stahel Cancer treatment reviews 28 (5), 255-271, 2002 | 292 | 2002 |
| Circulating deoxyribonucleic acid as prognostic marker in non–small-cell lung cancer patients undergoing chemotherapy O Gautschi, C Bigosch, B Huegli, M Jermann, A Marx, E Chassé, ... Journal of Clinical Oncology 22 (20), 4157-4164, 2004 | 286 | 2004 |
| High thermal stability is essential for tumor targeting of antibody fragments: engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule … J Willuda, A Honegger, R Waibel, PA Schubiger, R Stahel, ... Cancer research 59 (22), 5758-5767, 1999 | 281 | 1999 |
| Staging and prognostic factors in small cell lung cancer: a consensus report RAR Stahel, R Ginsberg, K Havemann, FR Hirsch, D Ihde, J Jassem, ... Lung cancer 5 (4-6), 119-126, 1989 | 278 | 1989 |
